Page 100 - Clinical variability in Noonan syndrome with emphasison ear and eye

CHAPTER 6
References
1. Neel, B.G., H. Gu, and L. Pao, The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends in Biochemical Sciences, 2003. 28(6): p. 284-93.
2. Roberts, A.E., et al., Noonan syndrome. Lancet, 2013. 381(9863): p. 333-42.
3. Allanson, J.E., Noonan syndrome. Journal of Medical Genetics, 1987. 24(1): p. 9-13.
4. Sharland, M., et al., A clinical study of Noonan syndrome. Archives of Disease in Childhood,
1992. 67(2): p. 178-83.
5. Noonan, J.A., Noonan syndrome. An update and review for the primary pediatrician. Clinical
Pediatrics, 1994. 33(9): p. 548-55.
6. van der Burgt, I., Noonan syndrome. Orphanet Journal of Rare Diseases, 2007. 2: p. 4.
7. Aoki, Y., et al., Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK
pathway syndrome. Am J Hum Genet, 2013. 93(1): p. 173-80.
8. Aoki, Y., et al., Recent advances in RASopathies. J Hum Genet, 2016. 61(1): p. 33-9.
9. Maheshwari, M., et al., PTPN11 mutations in Noonan syndrome type I: detection of recurrent
mutations in exons 3 and 13. Human Mutation, 2002. 20(4): p. 298-304.
10. Tartaglia, M., et al., PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype- phenotype correlation, and phenotypic heterogeneity. American Journal of Human Genetics,
2002. 70(6): p. 1555-63.
11. Tartaglia, M., et al., Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2,
cause Noonan syndrome. Nature Genetics, 2001. 29(4): p. 465-8.
12. Sarkozy, A., M.C. Digilio, and B. Dallapiccola, Leopard syndrome. Orphanet Journal of Rare
Diseases, 2008. 3: p. 13.
13. Rauen, K.A., The RASopathies. Annual Review of Genomics and Human Genetics, 2013. 14:
p. 355-69.
14. Gorlin, R.J., R.C. Anderson, and J.H. Moller, The leopard (multiple lentigines) syndrome
revisited. Laryngoscope, 1971. 81(10): p. 1674-81.
15. Tartaglia, M., B.D. Gelb, and M. Zenker, Noonan syndrome and clinically related disorders.
Best Practice & Research. Clinical Endocrinology & Metabolism, 2011. 25(1): p. 161-79.
16. Coppin, B.D. and I.K. Temple, Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis). Journal of Medical Genetics, 1997. 34(7): p. 582-6.
17. Sarkozy, A., et al., Clinical and molecular analysis of 30 patients with multiple lentigines
LEOPARD syndrome. Journal of Medical Genetics, 2004. 41(5): p. e68.
18. van Trier, D.C., et al., External ear anomalies and hearing impairment in Noonan Syndrome.
Int J Pediatr Otorhinolaryngol, 2015.
19. Bom, S.J., et al., Speech recognition scores related to age and degree of hearing impairment
in DFNA2/KCNQ4 and DFNA9/COCH. Arch Otolaryngol Head Neck Surg, 2001. 127(9): p.
1045-8.
20. Bosman, A.J. and G.F. Smoorenburg, Intelligibility of Dutch CVC syllables and sentences for
listeners with normal hearing and with three types of hearing impairment. Audiology, 1995.
34(5): p. 260-84.
21. Scheiber, C., et al., Bilateral cochlear implantation in children with Noonan syndrome. Int J
Pediatr Otorhinolaryngol, 2009. 73(6): p. 889-94.
22. Chu, H.S., et al., Syndromic Hearing Loss in Association with PTPN11-Related Disorder:
The Experience of Cochlear Implantation in a Child with LEOPARD Syndrome. Clin Exp
Otorhinolaryngol, 2013. 6(2): p. 99-102.
23. Cremers, C.W. and C.J. van der Burgt, Hearing loss in Noonan syndrome. International
Journal of Pediatric Otorhinolaryngology, 1992. 23(1): p. 81-4.
24. Naficy, S., N.T. Shepard, and S.A. Telian, Multiple temporal bone anomalies associated with
Noonan syndrome. Otolaryngology and Head and Neck Surgery, 1997. 116(2): p. 265-7.
25. Gelb, B.D. and M. Tartaglia, LEOPARD Syndrome, in GeneReviews(R), R.A. Pagon, et al.,
Editors. 1993: Seattle (WA).
98